Bone Marrow TransplantationBone MarrowBone Marrow CellsTransplantation, HomologousGraft vs Host DiseaseBone and BonesTransplantation, AutologousWhole-Body IrradiationAnemia, AplasticLeukemiaHematopoietic Stem Cell TransplantationBone Marrow DiseasesHematopoietic Stem CellsTransplantation ConditioningBone Marrow PurgingTissue DonorsGraft SurvivalBone Marrow ExaminationTransplantation ChimeraHistocompatibility TestingBone Marrow NeoplasmsBusulfanHematopoiesisBone RemodelingHistocompatibilityKidney TransplantationMice, Inbred C57BLCyclophosphamideTransplantation, IsogeneicLiver TransplantationRadiation ChimeraImmunosuppressive AgentsLeukemia, Myeloid, AcuteGraft RejectionRecurrenceLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTime FactorsHematologic NeoplasmsTreatment OutcomeCombined Modality TherapyColony-Forming Units AssayPrecursor Cell Lymphoblastic Leukemia-LymphomaImmunosuppressionBone DensityLeukemia, MyeloidRemission InductionCytomegalovirus InfectionsAcute DiseaseGraft vs Host ReactionHepatic Veno-Occlusive DiseaseLymphocyte DepletionBone ResorptionCell DifferentiationMyelodysplastic SyndromesT-LymphocytesRetrospective StudiesTransplantation ImmunologyCyclosporineLymphoma, Non-HodgkinSurvival AnalysisHeart TransplantationHLA AntigensStem Cell TransplantationChimeraHematologic DiseasesLeukocyte TransfusionSevere Combined ImmunodeficiencyCells, CulturedFlow CytometryPancytopeniaSpleenLeukocyte CountLung TransplantationBone NeoplasmsLymphocyte TransfusionNuclear FamilyAntigens, CD34Multiple MyelomaMice, Inbred BALB CActuarial AnalysisGranulocyte Colony-Stimulating FactorSurvival RateFollow-Up StudiesGranulocytesAntineoplastic Combined Chemotherapy ProtocolsOpportunistic InfectionsFatal OutcomeStromal CellsImmunocompromised HostBone DevelopmentDisease-Free SurvivalMice, KnockoutBone DiseasesLymphomaCell SeparationImmunophenotypingCytarabineTransplantationGraft vs Tumor EffectAntilymphocyte Serum